BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20648432)

  • 1. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
    Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
    Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulsed Doppler echocardiographic assessment of diastolic left ventricular hemodynamics in hypertrophic cardiomyopathy: relationship between the mode of left ventricular filling and the distribution of left ventricular hypertrophy].
    Oki T; Asai M; Takemura H; Fukuda N; Sakai H; Tominaga T; Murao A; Ohshima C; Kusaka Y; Niki T
    J Cardiogr; 1983 Sep; 13(3):523-35. PubMed ID: 6687193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Harrigan CJ; Appelbaum E; Maron BJ; Buros JL; Gibson CM; Lesser JR; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2008 Mar; 101(5):668-73. PubMed ID: 18308018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
    Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; Cecchi F; Salton CJ; Udelson JE; Manning WJ; Maron BJ
    J Am Coll Cardiol; 2008 Aug; 52(7):559-66. PubMed ID: 18687251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular involvement in hypertrophic cardiomyopathy.
    Maron MS; Hauser TH; Dubrow E; Horst TA; Kissinger KV; Udelson JE; Manning WJ
    Am J Cardiol; 2007 Oct; 100(8):1293-8. PubMed ID: 17920373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular involvement in right ventricular dysplasia/cardiomyopathy.
    Lobo FV; Silver MD; Butany J; Heggtveit HA
    Can J Cardiol; 1999 Nov; 15(11):1239-47. PubMed ID: 10579739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
    J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional heterogeneity of left ventricular myocardial work quantified using anatomical M-mode echocardiography.
    Kanzaki H; Nakatani S; Nakasone I; Katsuki K; Miyatake K
    Basic Res Cardiol; 2004 May; 99(3):204-11. PubMed ID: 15088105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature of cardiac hypertrophy in acromegaly: an echocardiographic study.
    Hradec J; Marek J; Petrásek J
    Cor Vasa; 1988; 30(3):186-99. PubMed ID: 3168477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biventriculographic and clinicopathologic evaluation of apical hypertrophy: with reference to asymmetrical septal hypertrophy with hypertension].
    Genda A; Taga K; Nakayama A; Nunoda S; Horita Y; Sugihara N; Takeda R
    J Cardiogr; 1985 Jun; 15(2):327-38. PubMed ID: 4093618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.